KLTO (Klotho Neurosciences) Scaled Net Operating Assets : 0.47 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Klotho Neurosciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Klotho Neurosciences's operating assets for the quarter that ended in Sep. 2024 was $2.41 Mil. Klotho Neurosciences's operating liabilities for the quarter that ended in Sep. 2024 was $0.85 Mil. Klotho Neurosciences's Total Assets for the quarter that ended in Jun. 2024 was $3.31 Mil. Therefore, Klotho Neurosciences's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.47.

Klotho Neurosciences Scaled Net Operating Assets Historical Data

The historical data trend for Klotho Neurosciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klotho Neurosciences Scaled Net Operating Assets Chart

Klotho Neurosciences Annual Data

Trend

Dec21

Dec22

Scaled Net Operating Assets

0.70

2.35

Klotho Neurosciences Quarterly Data
	Dec21	Jun22	Dec22	Jun23	Sep23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial			0.81	-	-	0.66	0.47

Competitive Comparison of Klotho Neurosciences's Scaled Net Operating Assets

For the Biotechnology subindustry, Klotho Neurosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klotho Neurosciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Klotho Neurosciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Klotho Neurosciences's Scaled Net Operating Assets falls into.

Klotho Neurosciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Klotho Neurosciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2022 )
=	(Operating Assets (A: Dec. 2022 )	-	Operating Liabilities (A: Dec. 2022 ))	/	Total Assets (A: Dec. 2021 )
=	(2.463	-	0.012)	/	1.042
=	2.35

where

	Operating Assets		(A: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2.539	-	0.076
=	2.463

	Operating Liabilities		(A: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.36	-	0	-	1.348
=	0.012

Klotho Neurosciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(2.413	-	0.853)	/	3.309
=	0.47

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2.464	-	0.051
=	2.413

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.004	-	0	-	0.151
=	0.853

Klotho Neurosciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Klotho Neurosciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Klotho Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

13576 Walnut Street, 12th Floor, Omaha, NE, USA, 68144

Website

https://www.klothoneuro.com

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.